Tiny freeze-dried pellets that include all the molecular machinery needed to translate DNA into proteins could form the basis for on-demand production of drugs and vaccines.
Developed by researchers at MIT and other institutions, the pellets, which contain dozens of enzymes and other molecules extracted from cells, can be stored at room temperature. When water and freeze-dried DNA are added, the pellets begin producing proteins encoded by the DNA.
“It’s a modular system that can be programmed to make what you need, on the spot,” says James Collins, a professor of biological engineering who is also the Termeer Professor of Medical Engineering and Science in MIT’s Institute for Medical Engineering and Science (IMES).
The freeze-dried pellets, which remain stable for at least a year, consist of a few dozen enzymes, DNA, and RNA, as well as ribosomes and other molecular machines necessary to translate the DNA into proteins. Only a few millimeters in diameter, they could easily be carried by soldiers, astronauts, or health-care workers heading to remote areas, Collins says.
Such pellets could be used to generate a wide range of products, including not only drugs and vaccines but molecules that could be used to diagnose illness. This could prove easier than using live cells to generate biopharmaceuticals, because the freeze-dried components are easy to store and ship, and they don’t need to be refrigerated.
“It could be used in a very simple carry kit for health-care workers going into the field in developing regions,” Collins says. “We think it could be very useful for the military, when you’re going out on a mission in the field, or for hikers and athletes going for long hauls. You could even have it in the back of your car as an expanded first aid kit.”
The big new idea for making self-driving cars that can go anywhere
The mainstream approach to driverless cars is slow and difficult. These startups think going all-in on AI will get there faster.
Inside Charm Industrial’s big bet on corn stalks for carbon removal
The startup used plant matter and bio-oil to sequester thousands of tons of carbon. The question now is how reliable, scalable, and economical this approach will prove.
The dark secret behind those cute AI-generated animal images
Google Brain has revealed its own image-making AI, called Imagen. But don't expect to see anything that isn't wholesome.
The hype around DeepMind’s new AI model misses what’s actually cool about it
Some worry that the chatter about these tools is doing the whole field a disservice.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.